Expression and Prognostic Significance of Wnt7a in Human Endometrial Carcinoma

Table 1

Relationship between the expression of Wnt7a and clinicopathological parameters of endometrial carcinoma.

Variable	Number	Wnt7a (%)		𝑃^∗-value
		Negative	Positive
Total	70	44 (62.9)	26 (37.1)
Age (years)				0.927
≤60	22	14 (63.6)	8 (36.4)
>60	48	30 (62.5)	18 (37.5)
FIGO stage				0.001
I+II	39	18 (46.2)	21 (53.8)
III+IV	31	26 (83.9)	5 (16.1)
Grade				0.001
G1	30	12 (40.0)	18 (60.0)
G2 + G3	40	32 (80.0)	8 (20.0)
Lymph node metastasis				0.002
Negative	49	25 (51.0)	24 (49.0)
Positive	21	19 (90.5)	2 (9.5)
Depth of myometrial invasion				0.006
≤1/2	31	14 (45.2)	17 (54.8)
>1/2	39	30 (76.9)	9 (23.1)
LVS involvement				0.001
Negative	44	21 (47.7)	23 (52.3)
Positive	26	23 (88.5)	3 (11.5)
Peritoneal cytology				0.013
Negative	53	29 (54.7)	24 (45.3)
Positive	17	15 (88.2)	2 (11.8)

FIGO: International Federation of Gynecology and Obstertics; LVS: lymph vascular space and *Chi-square test.